Generic placeholder image

Current Pediatric Reviews

Editor-in-Chief

ISSN (Print): 1573-3963
ISSN (Online): 1875-6336

Research Article

Group A Streptococcal Infections in Children

Author(s): Molla Imaduddin Ahmed*, Rosalind V. Saunders and Srini Bandi

Volume 17, Issue 1, 2021

Published on: 04 July, 2020

Page: [70 - 73] Pages: 4

DOI: 10.2174/1573396316666200704152246

Price: $65

Abstract

Background: Invasive group A streptococcal disease (iGAS) can have varied clinical presentations in children, are responsible for prolonged hospital stays and can cause mortality and long-term morbidity in children. Over the last decade, there has been an increase in the incidence of iGAS infections in the UK and worldwide. This has renewed the focus on early diagnosis, management and prevention of this disease.

Aims and Objectives: The aim of this study was to review the varied clinical presentations and management of children with iGAS infections.

Methods: We reviewed the data of children admitted to our tertiary Children’s Hospital who had positive isolation of Group A Streptococcus( GAS) from sterile site cultures over the last 8 years. We reviewed their clinical presentations and management including treatment given (antibiotics and duration), outcome and follow up.

Results: A total of 57 children had iGAS during the study period. The incidence of iGAS was 6-7 cases per year during the study period, except for 2015 when we had 11 cases. The mean length of stay of children admitted with iGAS was 11 days (range 2– 35 days). 21.1% children were admitted to intensive care during their hospital stay. Fever was the most common presenting symptom. Pneumonia with or without empyema was the most common Diagnosis. Initial antibiotic management was varied with ceftriaxone the most commonly used antibiotic in 30% of the cases. 50% of children had their antimicrobial therapy optimised to IV benzylpenicillin after the confirmed isolation of GAS. 7 Children were re-admitted for further treatment and needed a further course of antibiotics. 4 children (7%) died due to iGAS infection.

Conclusion: Our study highlighted the varied symptomatology and management practices in children with iGAS and showed that early diagnosis and prompt initiation of appropriate antibiotics for iGAS can help in the resolution of symptoms and good outcomes.

Keywords: Invasive, streptococcus, Group A, infections, children, iGAS.

« Previous
[1]
Lees EA, Carrol ED. Treating invasive Group A Streptococcal infections. Paediatrics and Child health. Symposium. Infect Immun 2014; 24(6): 242-7.
[http://dx.doi.org/10.1016/j.paed.2014.01.001]
[2]
Tapiainen T, Launonen S, Renko M, et al. Invasive Group A streptococcal infections in children: A nationwide survey in Finland. Pediatr Infect Dis J 2016; 35(2): 123-8.
[http://dx.doi.org/10.1097/INF.0000000000000945] [PMID: 26440814]
[3]
Oliver J, Thielemans E, McMinn A, et al. Invasive group A Streptococcus disease in Australian children: 2016 to 2018 - a descriptive cohort study. BMC Public Health 2019; 19(1): 1750.
[http://dx.doi.org/10.1186/s12889-019-8085-2] [PMID: 31888568]
[4]
Group A streptococcal infections: seasonal activity, 2017/18: third report : Health Protection Report 2018; 12(13)
[5]
Moses AE, Ziv A, Harari M, Rahav G, Shapiro M, Englehard D. Increased incidence and severity of Streptococcus pyogenes bacteremia in young children. Pediatr Infect Dis J 1995; 14(9): 767-70.
[http://dx.doi.org/10.1097/00006454-199509000-00007] [PMID: 8559625]
[6]
Laupland KB, Davies HD, Low DE, Schwartz B, Green K, McGeer A. Invasive group A streptococcal disease in children and association with varicella-zoster virus infection. Pediatrics 2000; 105(5)E60
[http://dx.doi.org/10.1542/peds.105.5.e60] [PMID: 10799624]
[7]
Tyrrell GJ, Lovgren M, Kress B, Grimsrud K. Varicella-associated invasive group A streptococcal disease in Alberta, Canada--2000-2002. Clin Infect Dis 2005; 40(7): 1055-7.
[http://dx.doi.org/10.1086/428614] [PMID: 15825001]
[8]
Mitchell S, Jones L. A strep in the wrong direction – invasive group a streptococcal disease ADC 2011; 96: 51.
[9]
Carapetis JR, Jacoby P, Carville K, Ang SJ, Curtis N, Andrews R. Effectiveness of clindamycin and intravenous immunoglobulin, and risk of disease in contacts, in invasive group a streptococcal infections. Clin Infect Dis 2014; 59(3): 358-65.
[http://dx.doi.org/10.1093/cid/ciu304] [PMID: 24785239]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy